A safety data exchange agreement is negotiated once, signed as an annex to a licensing or distribution contract, and then governs daily operational duties for as long as the partnership lasts. The document itself is usually filed carefully. What happens next is less reliable. The transfer windows, reconciliation cadences, literature screening scope and named contacts inside it rarely appear anywhere a pharmacovigilance operations team can see, which means they are managed from institutional memory and a shared calendar.
That gap is uncomfortable for a specific reason. Most SDEA obligations are not annual commitments that can be reviewed at renewal. They are commitments measured in days and hours, and the partner-to-partner clock sits inside a regulatory clock that does not move. A delayed case transfer between two companies is a contract issue on paper and a potential late regulatory submission in practice.
This guide sets out which SDEA provisions need active tracking, how to convert them into obligations with owners and cadences, and what inspectors ask for when they test whether the agreement was followed rather than merely signed. It is written for pharmacovigilance operations, alliance management and the contract teams who support them.
The provisions that need active tracking
Not every clause in an SDEA requires monitoring. The ones below do, because each creates a recurring duty with a deadline, a cadence or an evidence requirement rather than a one-time statement of intent.
- Case transfer windows, the time each party has to forward a valid individual case safety report to the other after becoming aware of it, usually expressed in calendar days from the date of first receipt.
- Reconciliation cadence, the frequency at which both parties compare case counts and identifiers, who initiates the exercise, and how discrepancies are investigated and formally closed.
- Literature screening scope, which party screens which databases, at what frequency, for which territories and products, and how findings are exchanged.
- Periodic report contributions, the data each party supplies for aggregate reports, the lead time before the submission date and the format the receiving party requires.
- Audit and inspection support, notice periods for partner audits, the obligation to notify the other party of a regulatory inspection, and the timeline for sharing findings that concern the shared product.
Read as a list, these look like standard contract terms. Read as operations, they are a schedule. Several recur monthly or quarterly, several have escalation consequences if missed, and all of them need a named owner on both sides who is still in the role. That combination is what makes SDEA management an obligation problem rather than a document problem, and it is why storing the agreement in a well-indexed repository does not by itself reduce risk.
Model the partner transfer window and the regulatory submission deadline together rather than separately. If a partner has a short window to forward a valid case and the marketing authorization holder then needs time for assessment and submission, the practical buffer may be very small. Setting escalation to fire partway through the partner window, rather than at its expiry, is the difference between a managed delay and a reportable one.
Turning clauses into tracked obligations
The conversion work is mechanical once the pattern is clear. Each tracked provision needs five attributes before it can be monitored, and an obligation record that is missing any of them will quietly stop being useful within a quarter.
- A named owner, by role. Assign to a role in the pharmacovigilance or alliance function rather than to an individual, and keep the role-to-person mapping in the identity system so departures do not orphan the obligation.
- A cadence or a trigger. Recurring duties such as reconciliation get a schedule. Event-driven duties such as case transfer get a trigger and a countdown, which behaves very differently and needs different alerting.
- An evidence requirement. State what proof closes the obligation, whether that is a reconciliation report, a transfer log extract or a signed training record. Obligations without a defined artifact are closed on assertion, which does not survive inspection.
- An escalation threshold. Define the point before the deadline at which the obligation escalates, and to whom. For transfer windows this should fire well inside the window, as covered in obligation management.
- A partner-side counterpart. Record the equivalent contact and duty on the other side, because most SDEA failures are joint failures and the first diagnostic question is which party held the ball.
A five-step implementation
Step 1, Inventory agreements by product and partner
Build a list of every product and partnership pair, then confirm an executed SDEA exists for each. Gaps are more common than teams expect, particularly where a distribution arrangement expanded into a new territory without the annex being revisited, or where a contract manufacturer began receiving complaints without a safety annex in place.
Step 2, Extract the trackable provisions
For each agreement, pull the transfer windows, reconciliation cadence, screening scope, report contributions and audit support terms into a structured register. AI clause extraction handles the retrieval well, but the values need pharmacovigilance review because SDEA drafting varies widely and a window expressed from awareness behaves differently from one expressed from receipt.
Step 3, Assign owners and cadences
Convert each register entry into an obligation with a role owner, a schedule or trigger, an evidence requirement and an escalation threshold. Resist the temptation to assign everything to the qualified person or the safety lead, because concentration in one role is what causes obligations to be missed during absence.
Step 4, Wire alerting to the tighter clock
Configure alerts against the partner transfer window rather than the regulatory deadline, with escalation partway through. For recurring duties, alert on the preparation lead time rather than the due date, since a reconciliation due at month end needs data pulled well before it.
Step 5, Close the change loop
Establish who updates the register when an agreement is amended, a partner changes contacts, a territory is added or a product is divested. Without a defined change process the register is accurate on the day it is built and progressively wrong afterwards, which is worse than having no register at all.
See SDEA clauses become tracked duties
A working session on one of your own safety annexes and the obligations inside it.
What inspection readiness actually requires
Inspectors testing a partnership generally work through three layers. They ask for the executed agreement covering the product and territory in scope, they ask for the version in force at the time of the cases they are examining, and then they ask for evidence that the agreed duties were performed during that period. The first two layers are document control and most organizations handle them. The third is where reconstruction begins, because demonstrating that transfers met the agreed window requires transfer times compared against the contractual figure, and demonstrating reconciliation requires completed reports with their discrepancy investigations closed out. Teams that keep this as a tracked obligation register produce the evidence as a report. The same principle applies across GxP contract obligations more broadly, as set out in the 21 CFR Part 11 and GxP audit checklist.
A tracking model by obligation type
SDEA duties fall into a small number of shapes, and each shape needs different monitoring. The table below shows the pattern most pharmacovigilance operations teams settle on, with the alerting approach that suits each.
| Obligation type | Trigger | Typical owner | Monitoring approach |
|---|---|---|---|
| Case transfer to partner | Awareness of a valid case | PV operations | Countdown with mid-window escalation |
| Case reconciliation | Recurring, monthly or quarterly | PV operations | Scheduled with preparation lead time |
| Literature screening | Recurring, weekly or monthly | Safety surveillance | Scheduled with scope confirmation |
| Aggregate report contribution | Fixed lead time before submission | PV scientist | Milestone with upstream data request |
| Inspection notification | Regulatory inspection notice received | Alliance management | Event-driven with same-day escalation |
The safety data exchange agreement is one of the clearest cases where contract value is realized entirely after signature. Nothing in the negotiated text reduces risk on its own. What reduces risk is a register where each recurring duty has an owner still in post, a cadence reflecting the tighter of the two clocks, an evidence artifact that closes it, and an escalation path that fires before a deadline rather than after.
For related guidance, see Co-promotion agreement obligations alliance teams miss, Expanded access program agreements, a control guide and DSCSA trading partner agreement control datasheet.
